Portfolio company
Radiant Biotherapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Avidicure
This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.
Reverb Therapeutics
This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.
Asher Biotherapeutics
This biotechnology company develops targeted immunotherapies for patients with cancer, infectious diseases and autoimmune conditions.
Hummingbird Bioscience
This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.
Ankyra Therapeutics
This biotechnology company develops anchored immunotherapy treatments for patients with cancer and other serious immune-mediated diseases.
Northern Biologics
This company develops antibody-based therapeutics targeting the tumour microenvironment to treat patients with cancer and fibrosis.
Ancora Biotech
The company develops multi-specific antibody therapeutics to treat patients with cancer, inflammatory disorders, and chronic hepatitis B infections.
Pionyr Immunotherapeutics
This company develops antibody therapeutics that modify the tumor microenvironment to treat cancer patients.
